FDA Inspection 1154327 — Oman Pharmaceutical Products Co. LLC
The FDA completed an inspection of Oman Pharmaceutical Products Co. LLC on February 8, 2020 in Central Salalah. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 8, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Central Salalah (Oman)
Additional Details
Mutual Recognition Agreement (MRA)